-
OKUR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
OnKure Therapeutics (OKUR)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 60.69 mm | 60.69 mm | 60.69 mm | 60.69 mm | 60.69 mm | 60.69 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.55 mm | 621.50 k | 4.33 mm | 1.73 mm |
Cash used (since last report) | n/a | n/a | 6.27 mm | 2.50 mm | 17.46 mm | 6.96 mm |
Cash remaining | n/a | n/a | 54.42 mm | 58.18 mm | 43.23 mm | 53.73 mm |
Runway (months of cash) | n/a | n/a | 35.0 | 93.6 | 10.0 | 31.1 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jan 25 | Agresta Samuel | Employee Stock Option Class A Common Stock | Grant | Acquire A | No | No | 5.19 | 45,000 | 233.55 k | 45,000 |
27 Jan 25 | Dylan Hartley | Employee Stock Option Class A Common Stock | Grant | Acquire A | No | No | 5.19 | 45,000 | 233.55 k | 45,000 |
27 Jan 25 | Leverone Jason A. | Employee Stock Option Class A Common Stock | Grant | Acquire A | No | No | 5.19 | 65,000 | 337.35 k | 65,000 |
27 Jan 25 | Nicholas A Saccomano | Employee Stock Option Class A Common Stock | Grant | Acquire A | No | No | 5.19 | 130,000 | 674.70 k | 130,000 |
7 Oct 24 | Braden Michael Leonard | Common Stock | Other | Acquire J | No | No | 0 | 102,076 | 0.00 | 102,076 |
7 Oct 24 | Braden Michael Leonard | Common Stock | Other | Acquire J | Yes | No | 0 | 345,739 | 0.00 | 345,739 |